Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Entera and OPKO, to upgrade the PTH tablet
09 February 2026

Entera and OPKO, to upgrade the PTH tablet

Introduction One of Miami’s diamonds, OPKO Healthcare Company, is working to establish robust pharmaceutical products for extreme conditions and continues to operate under BioReference Laboratories' supervision. The company is engaged in the development of treatments such as NGENLA and Rayald...

Biodexa finalized deal with Otsuka, and the new license of OPB-171775 arrives
09 February 2026

Biodexa finalized deal with Otsuka, and the new license of OPB-171775 arrives

Introduction Biodexa Pharmaceuticals PLC is a known clinical-level performer, a biopharmaceutical company concentrating on rare disease and oncology treatments. The gold of the company, MTX110, implements a sharp and effective solution to brain cancers. Its comprehensive, limited yet promising pipe...

‘PreCheck Program’ is a Direct Call to Manufacturers
05 February 2026

‘PreCheck Program’ is a Direct Call to Manufacturers

Introduction The U.S. Food and Drug Administration (FDA) is a centre for public health and well-being, a federal agency under the supervision of the Department of Health and Human Services. The agency is responsible for assessing the tolerability, efficacy, and safety of biological products, veteri...

TempraMed’s tech is soon to get a brand-level experience
05 February 2026

TempraMed’s tech is soon to get a brand-level experience

Introduction TempraMed Technologies Ltd., a smart and dedicated Vancouver-related medical technology company, acts as a shield to temperature-sensitive treatments with its valuable cameo in epinephrine and insulin access to patients smoothly and within an asked time. The company is popular for its ...

Did CD Genomics solve the concerns of Microbial?
05 February 2026

Did CD Genomics solve the concerns of Microbial?

Introduction CD Genomics is a leading contract research organisation (CRO) responsible for sequencing, bioinformatics and superior throughput genomics services. The company delivers its services to agricultural, pharmaceutical and university clients, covering 50+ regions globally. CD also offers be...

AstraZeneca gives more power to pharma’s investment
03 February 2026

AstraZeneca gives more power to pharma’s investment

Flashback Since 1999, AstraZeneca, through a merger with Zeneca Group and Astra AB, has become a single, one-stop company, as reflected in its name. This name justified its worth with its smart strategies and popular acquisition of Medlmmune for worth $15.2 billion in 2007. Later in 2013, the compa...

Seamless and Lilly into a Seamless Agreement to Loud their Research Game
02 March 2026

Seamless and Lilly into a Seamless Agreement to Loud their Research Game

Introduction Seamless Therapeutics, a well-known biotechnology company  operates its exclusive programmable recombinase platform to upgrade and modernise gene editing. Since the company came into the limelight due to a Technical University of Dresden spin-off, it has always concentrated on dis...

Cellares in High Demand
02 March 2026

Cellares in High Demand

Introduction Cellares is a leading Integrated Development and Manufacturing Organisation (IDMO) that provides full-fledged manufacturing services to boost scalability and reduce costs. The company believes in modernising its infrastructure and operations. This is the reason why Cellares is focusing...

Boehringer’s financial support for inflammatory bowel disease
30 January 2026

Boehringer’s financial support for inflammatory bowel disease

Introduction Boehringer Ingelheim, a known biopharmaceutical company, aims on animal health, biopharmaceuticals and human pharmaceuticals. The company is devoted to providing therapies in medical shortage areas where treatment is a must for metabolic, respiratory and cardiovascular diseases. This f...

BMS, along with Janux, is ready to upgrade cancer drugs
28 January 2026

BMS, along with Janux, is ready to upgrade cancer drugs

Introduction Bristol Myers Squibb (BMS), a leading biopharmaceutical company, aims to address immunology, cardiovascular, haematology, and oncology with its innovative and effective medicines, backed by a smart approach to discovering, establishing, and delivering excellence in these complex condit...